Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2021Journal of Allergy and Clinical ImmunologyOpen Access

Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJonathan I. SilverbergUniversity of VermontMBMarjolein de Bruin‐WellerUtrecht UniversityTBThomas BieberJohannes Kepler University of Linz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Silverberg et al. (2021) studied this question.

synapsesocial.com/papers/6aa014cb273ce704587c668ehttps://doi.org/10.1016/j.jaci.2021.07.036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial2019 · 366 citations
  2. 2A Population-Based Survey of Eczema Prevalence in the United States2007 · 351 citations
  3. 3Atopic dermatitis: Burden of illness, quality of life, and associated complications2017 · 107 citations
  4. 4In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)2018 · 393 citations